S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
NYSE:CNK

Cinemark Stock Forecast, Price & News

$15.21
-0.31 (-2.00%)
(As of 12/1/2021 04:00 PM ET)
Add
Compare
Today's Range
$15.20
$16.68
50-Day Range
$15.21
$22.11
52-Week Range
$13.20
$27.84
Volume
4.92 million shs
Average Volume
4.02 million shs
Market Capitalization
$1.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.4
30 days | 90 days | 365 days | Advanced Chart
Receive CNK News and Ratings via Email

Sign-up to receive the latest news and ratings for Cinemark and its competitors with MarketBeat's FREE daily newsletter.


Cinemark logo

About Cinemark

Cinemark Holdings, Inc. is a holding company, which engages in the provision of motion picture exhibition through its subsidiaries. It operates through the U.S. and International segments. The company was founded by Lee Roy Mitchell in 1984 and is headquartered in Plano, TX.

Headlines

Cinemark (NYSE:CNK) Shares Gap Up to $15.52
December 1, 2021 |  americanbankingnews.com
Is Cinemark Holdings Stock A Good Investment?
November 30, 2021 |  forbes.com
See More Headlines

Industry, Sector and Symbol

Industry
Motion picture theaters
Sub-Industry
Movies & Entertainment
CUSIP
17243V10
Employees
18,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$686.31 million
Book Value
$6.76 per share

Profitability

Net Income
$-616.83 million
Pretax Margin
-81.83%

Debt

Price-To-Earnings

Miscellaneous

Free Float
107,663,000
Market Cap
$1.82 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/05/2021
Today
12/02/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/25/2022

MarketRank

Overall MarketRank

2.03 out of 5 stars

Consumer Discretionary Sector

195th out of 388 stocks

Motion Picture Theaters Industry

3rd out of 4 stocks

Analyst Opinion: 3.2Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Cinemark (NYSE:CNK) Frequently Asked Questions

Is Cinemark a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cinemark in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Cinemark stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNK, but not buy additional shares or sell existing shares.
View analyst ratings for Cinemark
or view top-rated stocks.

How has Cinemark's stock price been impacted by Coronavirus?

Cinemark's stock was trading at $19.49 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CNK shares have decreased by 22.0% and is now trading at $15.21.
View which stocks have been most impacted by COVID-19
.

When is Cinemark's next earnings date?

Cinemark is scheduled to release its next quarterly earnings announcement on Friday, February 25th 2022.
View our earnings forecast for Cinemark
.

How were Cinemark's earnings last quarter?

Cinemark Holdings, Inc. (NYSE:CNK) announced its quarterly earnings results on Friday, November, 5th. The company reported ($0.65) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.70) by $0.05. The business had revenue of $434.80 million for the quarter, compared to analyst estimates of $428.65 million. Cinemark had a negative trailing twelve-month return on equity of 131.22% and a negative net margin of 70.88%. The company's revenue for the quarter was up 1124.8% on a year-over-year basis. During the same period in the previous year, the business earned ($1.25) EPS.
View Cinemark's earnings history
.

What price target have analysts set for CNK?

10 equities research analysts have issued twelve-month price objectives for Cinemark's shares. Their forecasts range from $14.00 to $31.00. On average, they anticipate Cinemark's stock price to reach $23.91 in the next year. This suggests a possible upside of 57.2% from the stock's current price.
View analysts' price targets for Cinemark
or view top-rated stocks among Wall Street analysts.

Who are Cinemark's key executives?

Cinemark's management team includes the following people:
  • Mark Zoradi, Chief Executive Officer & Director
  • Sean Gamble, President & Chief Operating Officer
  • Melissa Hayes Thomas, Chief Financial Officer & Executive Vice President
  • Damian Wardle, Executive VP-Theatre & Technology Operations
  • Doug Fay, Senior Vice President-Information Technology

What is Mark Zoradi's approval rating as Cinemark's CEO?

295 employees have rated Cinemark CEO Mark Zoradi on Glassdoor.com. Mark Zoradi has an approval rating of 73% among Cinemark's employees.

Who are some of Cinemark's key competitors?

What other stocks do shareholders of Cinemark own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cinemark investors own include Pfizer (PFE), Carnival Co. & (CCL), AT&T (T), Wells Fargo & Company (WFC), AMC Entertainment (AMC), Southwest Airlines (LUV), Tesla (TSLA), Exxon Mobil (XOM), Delta Air Lines (DAL) and Intel (INTC).

What is Cinemark's stock symbol?

Cinemark trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNK."

Who are Cinemark's major shareholders?

Cinemark's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (8.68%), Polaris Capital Management LLC (3.22%), Invesco Ltd. (2.09%), Barclays PLC (1.88%), Geode Capital Management LLC (1.48%) and Macquarie Group Ltd. (1.46%). Company insiders that own Cinemark stock include Lee Roy Mitchell, Mark Zoradi, Michael Cavalier, Valmir Fernandes and Ximena G Humrichouse.
View institutional ownership trends for Cinemark
.

Which major investors are selling Cinemark stock?

CNK stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Emerald Mutual Fund Advisers Trust, Millennium Management LLC, Strs Ohio, Allianz Asset Management GmbH, Dimensional Fund Advisors LP, Emerald Advisers LLC, and Russell Investments Group Ltd.. Company insiders that have sold Cinemark company stock in the last year include Michael Cavalier, and Valmir Fernandes.
View insider buying and selling activity for Cinemark
or view top insider-selling stocks.

Which major investors are buying Cinemark stock?

CNK stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Clal Insurance Enterprises Holdings Ltd, Polaris Capital Management LLC, Morgan Stanley, Barclays PLC, Hodges Capital Management Inc., Easterly Investment Partners LLC, and Victory Capital Management Inc.. Company insiders that have bought Cinemark stock in the last two years include Lee Roy Mitchell, Mark Zoradi, and Ximena G Humrichouse.
View insider buying and selling activity for Cinemark
or or view top insider-buying stocks.

How do I buy shares of Cinemark?

Shares of CNK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cinemark's stock price today?

One share of CNK stock can currently be purchased for approximately $15.21.

How much money does Cinemark make?

Cinemark has a market capitalization of $1.82 billion and generates $686.31 million in revenue each year. The company earns $-616.83 million in net income (profit) each year or ($5.62) on an earnings per share basis.

How many employees does Cinemark have?

Cinemark employs 18,000 workers across the globe.

What is Cinemark's official website?

The official website for Cinemark is www.cinemark.com.

Where are Cinemark's headquarters?

Cinemark is headquartered at 3900 DALLAS PARKWAY, PLANO TX, 75093.

How can I contact Cinemark?

Cinemark's mailing address is 3900 DALLAS PARKWAY, PLANO TX, 75093. The company can be reached via phone at (972) 246-3627, via email at [email protected], or via fax at 972-665-1008.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.